Lupin launches injectable iron formulations in India

Pharma major Lupin Limited said it launched Iron Isomaltoside injectable iron formulation under two brand names “Isofer” and “Jilazo” in India.

Lupin acquired the exclusive rights to market, distribute and sell the injectable formulation from Denmark based Pharmacosmos A/S.

The product is currently marketed in 33 countries, including 21 European Union countries under the brand name “Monofer”.

Iron Isomaltoside 1000 is indicated for the treatment of iron deficiency anemia when oral iron preparations are ineffective or cannot be used and when there is a clinical need to deliver iron rapidly. It is also used across a wide range of disease states associated with iron deficiency.

Lupin will promote Isofer and JIilazo injectable formulations through its own sales force in India.

The Hematinics market in India is currently worth around Rs 1931 cr and is growing at 11%. Out of this, the iron injectable market size is valued at Rs 310 crores with growth of 17% (IMS MAT AUG 2016).

More than 1 billion people live with iron deficiency anaemia and it is the leading cause of death for an estimated 180,000 people every year. Iron deficiency is often associated with many chronic diseases such as renal diseases including chronic kidney disease, cancers including chemotherapy induced anaemia, gynaecologic disorders including abnormal uterine bleeding and gastrointestinal diseases including inflammatory bowel disease.

Pharmacosmos A/S s a family-owned, international healthcare company headquartered in Denmark.

It is a research-based company, its ongoing R&D programme focuses on improving patients from the iron deficiency with or without anaemia.

Pharmacosmos has subsidiaries in the Nordics, the UK and the US and its products are marketed in more than 80 countries across the world.

Lupin manufactures a wide range of branded & generic formulations, biotechnology products and APIs globally.

For the financial year ended 31st March, 2016, Lupin’s Consolidated sales and Net profit stood at Rs 136,539 million ($ 2.09 billion) and Rs 22,607 million ($ 345 million) respectively.



Cipla redraws Iran plans with new agreement, to invest Rs 121 cr Cipla said its wholly owned subsidiary of the Company in Netherlands will set up a 75% joint venture with Ahran Tejarat Company for manufacturing and marketing of pharmaceutical products in Iran.An earlier agreement executed by the Company with the Iranian firm has been terminated.The total investment will be euro 16.875 million, which comes to about...
India traffic to porn sites jumps 3-8% in November Traffic from India to major pornographic websites in the world rose sharply in November.The numbers also reveal that Indians use the Internet for accessing pornographic content more often than globally.For example, according to similarweb.com, a website that collates monthly web analytics data, there were no pornographic websites included in the li...
Despite Demonetization, India will beat China in GDP growth: Fitch Ratings Despite a moderation in India's GDP growth rate in the short term due to cash crunch, the Indian economy will still grow faster than that of China, global ratings agency Fitch said."We still expect India’s GDP growth to trend higher than China’s in the medium term," said the agency, whose primary job is to advice bond buyers on risks involved in buying d...
Bliss GVS Healthcare wins three-year contract worth Rs 760 cr from Kenya Bliss GVS Healthcare Ltd said it won a three year contract worth $111.40 mln (Rs 760 cr) from Aon Kenya Insurance Brokers Ltd for provision of medical health care services in Kenya. Bliss GVS Pharma Ltd is a pharmaceutical company based in Mumbai, India.Bliss GVS primarily develops, manufactures and markets products across various therapeuti...
Alembic Pharmaceuticals receives FDA approval for hypertension tablets Alembic Pharmaceuticals Ltd said it received approval from the United States Food & Drug Administration for its abbreviated new drug application for Telmisartan and Amlodipine tablets for hypertension.The Telmisartan and Amlodipine Tablets are equivalent to the Twynsta tablets of Boehringer Ingelheim Pharmaceuticals, Inc.An Abbreviated New Drug ...
Dr Reddy’s Labs launches osteoporosis drug in the US Dr Reddy's Laboratories Ltd said it launched raloxifene hydrochloride tablets --used to treat osteoporosis -- in the US market.Raloxifene hydrochloride tablets are a therapeutic equivalent generic version of Evista (raloxifene hydrochloride) tablets. A generic drug is a pharmaceutical drug that is equivalent to a brand-name product in dosage, strength, r...
Uflex launches pouch to extend shelf life for ghee FMCG company Uflex said it launched new pouche for liquids like ghee or clarified butter for long shelf life.The pouch with sonically sealed spout has been offered to Paras Dairy for packing it's ghee.Uflex, founded in 1983, is India’s largest end-to-end flexible packaging company.Jeevaraj Pillai, Joint President, Packaging and New Product Develo...
Nikon launches DSLR D5600 camera Nikon India said it launched a new DSLR camera --Nikon D5600.The DX-format D-SLR is equipped with a vari-angle LCD monitor that flips out and rotates, touch screen operation enhanced with crop function for use use in playback zoom, frame advance bar for users to scroll through images in playback mode easily, time-lapse movie function, etc.The camera ...
Ambrane launches ´BT-5000´ bluetooth speaker @ Rs 1499 IT brand Ambrane India said it launched a new bluetooth speaker BT5000, priced at just Rs 1499.Ambrane is one of the leading IT brands in computer peripherals, Mobile Accessories and No. 1 in Power Banks.The speaker has in-built Magnetic trumpet that improves the quality of perceptible audio output giving the user a loud and crystal clear sound, the...
OnMobile launches new consumer brand ONMO OnMobile Global Limited launched its new consumer brand, ONMO, and showcased some of its other new products. “The company has been working towards this change for over two years now. It has made significant investments in core technology, product development, processes and people to get ready to serve consumers directly,” said the company.Onmobile ...
Sun Pharma to get dengue vaccine technology from ICGEB Pharma major Sun Pharma said it tied up with research organization International Centre for Genetic Engineering and Biotechnology to develop vaccines for dengue.The vaccine is targeted against all the four serotypes of Dengue virus that cause disease in humans and is being developed to commercialize in Indian and international markets.A serotype is a...
Aarti Industries to return Rs 96 cr to shareholders via buyback Speciality Chemicals company Aarti Industries Ltd said it will buy back12 lakh equity shares at Rs 800 each, aggregating to Rs 96 cr.The company´s Board of Directors approved the equity shares -- representing up to 1.44% of the company's base."The public announcement setting out the process, timelines and other requisite detail will be released in du...
Marksans Pharma gets USFDA approval for synthetic Vitamin D tablets Marksans Pharma Ltd said the United States Food & Drug Administration has given its approval for its paricalcitol capsules -- a synthetic equivalent of Vitamin D.Vitamin D is important for the absorption of Calcium from the stomach and for the functioning of Calcium in the body. Paricalcitol Capsules are therapeutically equivalent to the reference l...
India overdependent on China for medicines – study India may have emerged as a key supplier of generic and affordable medicine for the world market, but it has an "overwhelming dependence" on China for the raw material required to produce these drugs, industry association Assocham said.Indian companies depend on China to supply them with the main raw material in drug making -- known as Active Pharmaceuti...
IND Vs NZ: India win toss at Indore, to bat first Courtesy: Hotstar ScreengrabIndia won the toss and chose to bat first in the  third Paytm test match at Holkar Stadium, Indore.The pitch will favour the bowlers and batting would be difficult, was Sunil Gavaskar's opinion."It will be a batman friendly wicket", said Virat Kohli after winning the toss for the third time in the series.New Zeala...